Three-dimensional high-resolution magnetic resonance spectroscopic imaging for absolute quantification of 31P metabolites in human liver

Authors

  • M. Chmelík,

    1. Karl-Landsteiner Institute for Endocrinology and Metabolism, Vienna, Austria
    2. MR Centre of Excellence, Medical University of Vienna, Vienna, Austria
    Search for more papers by this author
  • A. I. Schmid,

    1. Karl-Landsteiner Institute for Endocrinology and Metabolism, Vienna, Austria
    2. MR Centre of Excellence, Medical University of Vienna, Vienna, Austria
    Search for more papers by this author
  • S. Gruber,

    1. MR Centre of Excellence, Medical University of Vienna, Vienna, Austria
    2. Department of Radiology, Medical University of Vienna, Vienna, Austria
    Search for more papers by this author
  • J. Szendroedi,

    1. Karl-Landsteiner Institute for Endocrinology and Metabolism, Vienna, Austria
    2. First Medical Department, Hanusch Hospital, Vienna, Austria
    Search for more papers by this author
  • M. Krššák,

    1. Department of Radiology, Medical University of Vienna, Vienna, Austria
    2. Department of Internal Medicine 3, Medical University of Vienna, Austria
    Search for more papers by this author
  • S. Trattnig,

    1. MR Centre of Excellence, Medical University of Vienna, Vienna, Austria
    2. Department of Radiology, Medical University of Vienna, Vienna, Austria
    Search for more papers by this author
  • E. Moser,

    1. MR Centre of Excellence, Medical University of Vienna, Vienna, Austria
    2. Center for Biomedical Engineering and Physics, Medical University of Vienna, Austria
    Search for more papers by this author
  • M. Roden

    Corresponding author
    1. Karl-Landsteiner Institute for Endocrinology and Metabolism, Vienna, Austria
    2. First Medical Department, Hanusch Hospital, Vienna, Austria
    • Karl-Landsteiner Institute of Endocrinology and Metabolism, Heinrich Collin Strasse 30, A-1140 Vienna, Austria
    Search for more papers by this author

Abstract

Liver dysfunction correlates with alterations of intracellular concentrations of 31P metabolites. Localization and absolute quantification should help to trace regional hepatic metabolism. An improved protocol for the absolute quantification of 31P metabolites in vivo in human liver was developed by employing three-dimensional (3D) k-space weighted spectroscopic imaging (MRSI) with B1-insensitive adiabatic excitation. The protocol allowed for high spatial resolution of 17.8 ± 0.22 cm3 in 34 min at 3 T. No pulse adjustment prior to MRSI measurement was necessary due to adiabatic excitation. The protocol geometry was identical for all measurements so that one calibration data set, acquired from phantom replacement measurement, was applied for all quantifications. The protocol was tested in 10 young, healthy volunteers, for whom 57 ± 7 spectra were quantified. Concentrations per liter of liver volume (reproducibilities) were 2.24 ± 0.10 mmol/L (1.8%) for phosphomonoesters (PME), 1.37 ± 0.07 mmol/L (7.9%) for inorganic phosphate (Pi), 11.40 ± 0.96 mmol/L (2.9%) for phosphodiesters (PDE), and 2.14 ± 0.10 mmol/L (1.6%) for adenosine triphosphate (ATP), respectively. Taken together, this approach provides fast, simple, and reproducible high-resolution absolute quantification and detailed mapping of the spatial distribution of hepatic 31P metabolites. This method allows for examination of regional deviations of energy metabolism in human liver diseases. Magn Reson Med 60:796–802, 2008. © 2008 Wiley-Liss, Inc.

Ancillary